0001465584-14-000001.txt : 20140429
0001465584-14-000001.hdr.sgml : 20140429
20140429140055
ACCESSION NUMBER: 0001465584-14-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140429
DATE AS OF CHANGE: 20140429
EFFECTIVENESS DATE: 20140429
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics Holdings, LLC
CENTRAL INDEX KEY: 0001465584
IRS NUMBER: 261870083
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-216462
FILM NUMBER: 14793058
BUSINESS ADDRESS:
STREET 1: 1421 STATE ST., STE. B
CITY: SANTA BARBARA
STATE: CA
ZIP: 93101
BUSINESS PHONE: 805-966-2440
MAIL ADDRESS:
STREET 1: 1421 STATE ST., STE. B
CITY: SANTA BARBARA
STATE: CA
ZIP: 93101
FORMER COMPANY:
FORMER CONFORMED NAME: CytomX Therapeutics, LLC
DATE OF NAME CHANGE: 20090604
D
1
primary_doc.xml
X0707
D
LIVE
0001465584
CytomX Therapeutics Holdings, LLC
1421 STATE ST., STE. B
SANTA BARBARA
CA
CALIFORNIA
93101
805-966-2440
CALIFORNIA
CytomX Therapeutics, LLC
Limited Liability Company
true
Gary
Wilcox
1421 State St. Ste. B
Santa Barbara
CA
CALIFORNIA
93101
Director
Manager
Alan
Heeger
1421 St ate St. Ste. B
Santa Barbara
CA
CALIFORNIA
9310 1
Director
Manager
Michael
Pfau
1421 State St. Ste. B
Santa Barbara
CA
CALIFORNIA
93101
Executive Officer
Secretary
Other
Not Applicable
- 06b
false
2014-04-24
false
true
true
Series B-1 Preferred Units
false
0
2500000
1423488
1076512
Proceeds used to fund the purchase of Series B-1 Preferred Stock in CytomX Therapeutics, Inc.
false
25
0
0
0
false
CytomX Therapeutics Holdings, LLC
/s/ Michael E. Pfau
Michael E. Pfau
Secretary
2014-04-29